Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Nivolumab 25 pembrolizumab 20 Ipilimumab 15 toripalimab 12 Temozolomide 11 Biopsy 8 Dacarbazine 7 Cyclophosphamide 6 Blood Specimen Collection 6 trametinib 5 fludarabine 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 Gene Expression Profiling 5 Chemotherapy, Adjuvant 5 durvalumab 4 binimetinib 4 aldesleukin 4 Interleukin-2 4 Injections 4 Carboplatin 4 tislelizumab 3 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Paclitaxel 3 Introns 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × Toll-Like Receptor 1 × Clear all

NCT03374839 2022-05-06

Nivo-TIL

Nantes University Hospital

Phase 1/2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡